User:Mr. Ibrahem/Ocriplasmin

Ocriplasmin, sold under the brand name Jetrea, is a medication used for vitreomacular traction. It is used for milder disease and may prevent the need for surgery. It is given by injection into the eye.

Common side effects include floaters, eye pain, flashes of light, and conjunctival bleeding. Other side effects may include intraocular bleeding, increased intraocular pressure, and intraocular infection. It is similar to natural plasmin and works by breaking down proteins between the vitreous and the retina.

Ocriplasmin was approved for medical use in the United States in 2012 and Europe in 2013. In the United Kingdom it costs the NHS £2,500 per 0.375 mg vial as of 2021. This amount in the United States costs about 3,100 USD.